ELUT Stock Analysis: Buy, Sell, or Hold?

ELUT - Elutia Inc. Class A Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$1.03
0.03 (3.00%) ▲
5d: +6.35%
30d: -14.17%
90d: -7.21%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026

Get Alerted When ELUT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: ELUT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ELUT is currently trading at $1.03, which is considered fair relative to its 30-day fair value range of $0.98 to $1.13.

Technical Outlook: Technically, ELUT is in a uptrend. Immediate support is located at $0.95, while resistance sits at $1.18. The stock is showing strong short-term momentum, up 3.0% recently.

Market Sentiment: ELUT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+385.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.98 - $1.13
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 92.1%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.0%)
  • BULLISH: Trading 385.4% below Wall St target ($5.00)

Trading Range Analysis

30-Day Trading Range $0.98 - $1.13
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.95
Resistance Level $1.18
Current Trend Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.98
Wall Street Target $5.00 (+385.4%)
Revenue Growth (YoY) -48.4%
Profit Margin 400.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 5:10 PM ET
Data refreshes hourly during market hours. Next update: 6:10 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Guido J Neels BUY 20000 shares 2026-01-30
Kevin Rakin BUY 70000 shares 2026-01-30
Guido J Neels BUY 15000 shares 2026-01-28

Unlock Insider Activity

See real-time buying/selling by company executives for ELUT.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$77 60 HOLD
DXCM
DexCom Inc
STRONG BUY
27 analysts
$85 57 HOLD
SYK
Stryker Corporation
BUY
32 analysts
$387 61 BUY
PODD
Insulet Corporation
STRONG BUY
24 analysts
$242 61 BUY
ABT
Abbott Laboratories
STRONG BUY
27 analysts
$117 59 HOLD

More Analysis for ELUT

ELUT Technical Chart ELUT Price Prediction ELUT Earnings Date ELUT Investment Advisor ELUT Fair Price Analyzer ELUT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals